The Latest in Hepatology

Lysosomal acid lipase replacement corrects rare genetic cause of liver failure, atherosclerosis

January 4, 2017

VIDEO: NAFLD costing U.S. $290 billion annually

December 13, 2016

Hepatitis Outlook: November 2016

December 8, 2016

VIDEO: Angiogenesis has a role to play in NASH and NAFLD

December 7, 2016

Fecal calprotectin tops CRP as Crohn’s marker

December 2, 2016

The Liver Meeting 2016 debrief – key abstracts

November 30, 2016

Hepatitis Outlook: October 2016

November 29, 2016

VIDEO: Appealing DAA denials is worth it for hepatitis C patients

November 28, 2016

Hepatology

Sofosbuvir/velpatasvir improved patient-reported outcomes, knocked out HCV genotypes 1-6

November 21, 2016

Tumor boards linked to improved survival in hepatocellular carcinoma

November 21, 2016

Direct-acting antiretrovirals in genotype 1 HCV patients with mental health conditions safe, well tolerated

November 18, 2016

VIDEO: PBC patients with compensated cirrhosis fare well on obeticholic acid

November 17, 2016

SNP predicts liver cancer in hepatitis C patients regardless of SVR

November 17, 2016

Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitis

November 16, 2016

Medicaid restrictions loosening on access to HCV therapies

November 16, 2016